Considering Stealth Approaches for Allogeneic Therapies to Avoid Immune System Detection

Time: 10:00 am
day: Day One


• Exploring use of siRNA, shRNA, and microRNA to silence immunogenic signalling in

allogeneic T-cells

• Understanding the benefits awarded to patients by optimising

• Potency vs stealth: evaluating prioritisation of therapy characteristic dependent on

disease type and severity